Market regulator Securities and Exchange Board of India (SEBI) has cleared Piramal Pharma Ltd (PPL) of allegations concerning ...

The Securities and Exchange Board of India (SEBI) on November 8 cleared Piramal Pharma Limited (PPL) of allegations ...

Till 12:35 pm; a combined 32.3 million shares representing 2.43 per cent of total equity of PPL changed hands on the NSE and BSE.

Piramal Pharma's company's revenue for the quarter under review stood at Rs 2,242 crore as compared to Rs 1,911 crore which implies an increase of 17 per cent Y-o-Y ...

Piramal Pharma (PPL) has been exonerated in a case related to alleged non-disclosure of material information to the ...

Piramal Pharma Ltd released its fiscal second quarter earnings with profit at Rs 22.59 crore. (Image Source: Unsplash) Piramal Pharma Ltd on Wednesday released its fiscal second quarter earnings ...

Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global ...

Shares of Piramal Pharma jumps over 4% to intra-day high of Rs 230 on NSE today after the company reported a strong financial performance for the second quarter of FY25. The company’s net profit ...

Chennai: Pharma market reported better revenue growth in Q2 FY25 against the year-ago quarter, mainly driven by price rise ...

Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global ...

Shares of Piramal Pharma Ltd surged 18.32 per cent after having opened strongly at ₹227.90 as against the previous closing of ₹216.70 on wednesday. The stock hit high of ₹260.00 and low of ...

Piramal Pharma Q2 Results Live : Piramal Pharma declared their Q2 results on 23 Oct, 2024, showcasing robust financial performance. The company's topline saw a significant increase of 17.28% year ...